Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR

Sarcomas differ from carcinomas in their mesenchymal origin. Therapeutic advancements have come slowly so alternative drugs and models are urgently needed. These studies report a new drug for sarcomas that simultaneously targets both tumor and tumor neovasculature. eBAT is a bispecific angiotoxin co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Borgatti, Antonella, Koopmeiners, Joseph S., Sarver, Aaron L., Winter, Amber L., Stuebner, Kathleen, Todhunter, Deborah, Rizzardi, Anthony E., Henriksen, Jonathan C., Schmechel, Stephen, Forster, Colleen L., Kim, Jong-Hyuk, Froelich, Jerry, Walz, Jillian, Henson, Michael S., Breen, Matthew, Lindblad-Toh, Kerstin, Oh, Felix, Pilbeam, Kristy, Modiano, Jaime F., Vallera, Daniel A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5418099/
https://ncbi.nlm.nih.gov/pubmed/28193671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-16-0637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados